ScoreWhy is Jiangsu Yahong Meditech Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 0%
- The company has reported losses and also has negative networth. This is not a good sign for the investors. Either company will have to raise fresh capital or report profits to sustain going forward
2
Poor long term growth as Net Sales has grown by an annual rate of 309.07% and Operating profit at -15.64% over the last 5 years
3
Flat results in Sep 25
- INTEREST(HY) At CNY 7.18 MM has Grown at 67.12%
- ROCE(HY) Lowest at -18.95%
4
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 39.93%, its profits have risen by 7.7%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Jiangsu Yahong Meditech Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Jiangsu Yahong Meditech Co., Ltd.
60.76%
2.31
47.76%
China Shanghai Composite
17.07%
1.58
14.20%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
309.07%
EBIT Growth (5y)
-15.64%
EBIT to Interest (avg)
-167.88
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.82
Sales to Capital Employed (avg)
0.06
Tax Ratio
0.13%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.30
EV to EBIT
-11.30
EV to EBITDA
-12.35
EV to Capital Employed
14.94
EV to Sales
18.00
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-132.22%
ROE (Latest)
-20.87%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend14What is working for the Company
NET PROFIT(HY)
Higher at CNY -169.32 MM
RAW MATERIAL COST(Y)
Fallen by -8.69% (YoY
NET SALES(Q)
Highest at CNY 86.17 MM
OPERATING PROFIT MARGIN(Q)
Highest at -108.82 %
-12What is not working for the Company
INTEREST(HY)
At CNY 7.18 MM has Grown at 67.12%
ROCE(HY)
Lowest at -18.95%
Here's what is working for Jiangsu Yahong Meditech Co., Ltd.
Net Sales
At CNY 86.17 MM has Grown at 47.41%
Year on Year (YoY)MOJO Watch
Near term sales trend is very positive
Net Sales (CNY MM)
Net Profit
Higher at CNY -169.32 MM
than preceding 12 month period ended Sep 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (CNY MM)
Net Sales
Highest at CNY 86.17 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Operating Profit Margin
Highest at -108.82 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Raw Material Cost
Fallen by -8.69% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Jiangsu Yahong Meditech Co., Ltd.
Interest
At CNY 7.18 MM has Grown at 67.12%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
